Cargando…

MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2

BACKGROUND: An increasing body of evidence indicates that miRNAs have a critical role in carcinogenesis and cancer progression; however, the role of miRNAs in the tumorigenesis of adencarcinoma of gastric esophageal junction (AGEJ) remains largely unclear. METHODS: The SGC7901 and BGC-823 gastric ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiaoshan, Wang, Ying, Ma, Zhikun, Yang, Ruina, Liang, Shuo, Zhang, Mengxi, Song, Shiyuan, Li, Shuoguo, Liu, Gang, Fan, Daiming, Gao, Shegan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161885/
https://www.ncbi.nlm.nih.gov/pubmed/25174799
http://dx.doi.org/10.1186/1471-2407-14-633
_version_ 1782334614256222208
author Feng, Xiaoshan
Wang, Ying
Ma, Zhikun
Yang, Ruina
Liang, Shuo
Zhang, Mengxi
Song, Shiyuan
Li, Shuoguo
Liu, Gang
Fan, Daiming
Gao, Shegan
author_facet Feng, Xiaoshan
Wang, Ying
Ma, Zhikun
Yang, Ruina
Liang, Shuo
Zhang, Mengxi
Song, Shiyuan
Li, Shuoguo
Liu, Gang
Fan, Daiming
Gao, Shegan
author_sort Feng, Xiaoshan
collection PubMed
description BACKGROUND: An increasing body of evidence indicates that miRNAs have a critical role in carcinogenesis and cancer progression; however, the role of miRNAs in the tumorigenesis of adencarcinoma of gastric esophageal junction (AGEJ) remains largely unclear. METHODS: The SGC7901 and BGC-823 gastric cancer cell lines were used. The expressions of miR-645 and IFIT2 (Interferon-induced protein with tetratricopeptide repeats 2) were examined by qRT-PCR, The expressions of IFIT2 was examined by western blotting and immunohistochemistry assay. The cell apoptosis was determined by FACS. MiR-645 inhibitor, mimics and plasmid-IFIT2 transfections were performed to study the loss- and gain-function. Caspase-3/7 activity was examined by caspase-3/7 assay. RESULTS: In the present study, we have reported an increased expression of miR-645 in AGEJ clinical specimens compared with paired non-cancerous tissues. We also observed a significant miR-645 up-regulation in two gastric cancer (GC) cell lines, SGC7901 and BGC-823, which were used as cell models because there was no available AGEJ cell lines established to date. We found that inhibition of miR-645 could sensitize dramatically SGC7901 and BGC-823 cells to both serum starvation– and chemotherapeutic drug–induced apoptosis by up-regulating IFIT2, a mediator of apoptosis via a mitochondrial pathway, with a potential binding site for miR-645 in its mRNA’s 3′UTR. Further investigation exhibited that IFIT2 expression decreases in SGC7901 and BGC-823 cells and AGEJ tissues. IFIT2 ectopic expression leads to promotion of cell apoptosis, indicating that IFIT2 may function as a suppressor in the development of AGEJ. Furthermore, inhibition of miR-645 induces up-regulation of IFIT2 and increased caspase-3/7 activity compared with control groups. CONCLUSIONS: Our data suggest that miR-645 functions as an oncogene in human AGEJ by, at least partially through, targeting IFIT2. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-633) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4161885
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41618852014-09-13 MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2 Feng, Xiaoshan Wang, Ying Ma, Zhikun Yang, Ruina Liang, Shuo Zhang, Mengxi Song, Shiyuan Li, Shuoguo Liu, Gang Fan, Daiming Gao, Shegan BMC Cancer Research Article BACKGROUND: An increasing body of evidence indicates that miRNAs have a critical role in carcinogenesis and cancer progression; however, the role of miRNAs in the tumorigenesis of adencarcinoma of gastric esophageal junction (AGEJ) remains largely unclear. METHODS: The SGC7901 and BGC-823 gastric cancer cell lines were used. The expressions of miR-645 and IFIT2 (Interferon-induced protein with tetratricopeptide repeats 2) were examined by qRT-PCR, The expressions of IFIT2 was examined by western blotting and immunohistochemistry assay. The cell apoptosis was determined by FACS. MiR-645 inhibitor, mimics and plasmid-IFIT2 transfections were performed to study the loss- and gain-function. Caspase-3/7 activity was examined by caspase-3/7 assay. RESULTS: In the present study, we have reported an increased expression of miR-645 in AGEJ clinical specimens compared with paired non-cancerous tissues. We also observed a significant miR-645 up-regulation in two gastric cancer (GC) cell lines, SGC7901 and BGC-823, which were used as cell models because there was no available AGEJ cell lines established to date. We found that inhibition of miR-645 could sensitize dramatically SGC7901 and BGC-823 cells to both serum starvation– and chemotherapeutic drug–induced apoptosis by up-regulating IFIT2, a mediator of apoptosis via a mitochondrial pathway, with a potential binding site for miR-645 in its mRNA’s 3′UTR. Further investigation exhibited that IFIT2 expression decreases in SGC7901 and BGC-823 cells and AGEJ tissues. IFIT2 ectopic expression leads to promotion of cell apoptosis, indicating that IFIT2 may function as a suppressor in the development of AGEJ. Furthermore, inhibition of miR-645 induces up-regulation of IFIT2 and increased caspase-3/7 activity compared with control groups. CONCLUSIONS: Our data suggest that miR-645 functions as an oncogene in human AGEJ by, at least partially through, targeting IFIT2. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-633) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-29 /pmc/articles/PMC4161885/ /pubmed/25174799 http://dx.doi.org/10.1186/1471-2407-14-633 Text en © Feng et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Feng, Xiaoshan
Wang, Ying
Ma, Zhikun
Yang, Ruina
Liang, Shuo
Zhang, Mengxi
Song, Shiyuan
Li, Shuoguo
Liu, Gang
Fan, Daiming
Gao, Shegan
MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2
title MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2
title_full MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2
title_fullStr MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2
title_full_unstemmed MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2
title_short MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2
title_sort microrna-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor ifit2
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161885/
https://www.ncbi.nlm.nih.gov/pubmed/25174799
http://dx.doi.org/10.1186/1471-2407-14-633
work_keys_str_mv AT fengxiaoshan microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2
AT wangying microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2
AT mazhikun microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2
AT yangruina microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2
AT liangshuo microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2
AT zhangmengxi microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2
AT songshiyuan microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2
AT lishuoguo microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2
AT liugang microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2
AT fandaiming microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2
AT gaoshegan microrna645upregulatedinhumanadencarcinomaofgastricesophagealjunctioninhibitsapoptosisbytargetingtumorsuppressorifit2